speb/financial-data huggingface dataset:
DuPont ROE decomposition for CHIB.L (annual period ending 2022-03-31)
ROE: 2.1435957379849837%
Net margin: 81.81194234728896%
Asset turnover: 0.02443441949387043
Equity multiplier (leverage): 1.072319381378411
Tax burden factor: 0.9900332225913621
ROE archetype: Low Return
DuPont ROE decomposition for CHIB.L (annual period ending 2023-03-31)
ROE: -0.5235677881027526%
Asset turnover: -0.00012304970268925126
Equity multiplier (leverage): 1.0947502545137602
ROE archetype: Low Return
DuPont ROE decomposition for CHIB.L (annual period ending 2024-03-31)
ROE: 10.720040711015768%
Net margin: 95.34409515717927%
Asset turnover: 0.0991681842976063
Equity multiplier (leverage): 1.1337838630708805
Tax burden factor: 0.9973338073231425
ROE archetype: Standard Business
DuPont ROE decomposition for CHIB.L (annual period ending 2025-03-31)
ROE: 12.702634126278763%
Net margin: 96.4293071482524%
Asset turnover: 0.11495486819618818
Equity multiplier (leverage): 1.1459281157662624
Tax burden factor: 0.9977264653641207
ROE archetype: Standard Business
DuPont ROE decomposition for CHIB.L (annual period ending 2026-03-31)
ROE: 16.52624690517236%
Net margin: 97.49567008378973%
Asset turnover: 0.147282536117865
Equity multiplier (leverage): 1.1509001708676152
Tax burden factor: 0.9999039846375422
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CHKP (annual period ending 2022-12-31)
ROE: 27.204451575461718%
Net margin: 34.20318468603803%
Asset turnover: 0.4069836500838458
Equity multiplier (leverage): 1.9543235585293417
EBIT margin: 37.95441864457702%
Interest burden factor: 1.049756869840552
Tax burden factor: 0.8584509318108371
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CHKP (annual period ending 2023-12-31)
ROE: 28.809369987882526%
Net margin: 34.79935395701329%
Asset turnover: 0.4169409075889848
Equity multiplier (leverage): 1.9855831205884722
EBIT margin: 37.23443906075289%
Interest burden factor: 1.085085085085085
Tax burden factor: 0.8613161131611317
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CHKP (annual period ending 2024-12-31)
ROE: 30.02247983478503%
Net margin: 32.97076023391813%
Asset turnover: 0.4461955847285905
Equity multiplier (leverage): 2.040761874482637
EBIT margin: 34.15204678362573%
Interest burden factor: 1.109703196347032
Tax burden factor: 0.8699722250797244
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CHKP (annual period ending 2025-12-31)
ROE: 39.79054724051218%
Net margin: 38.77962867835914%
Asset turnover: 0.42518240570585086
Equity multiplier (leverage): 2.413242587386862
EBIT margin: 30.49460629632347%
Interest burden factor: 1.1371676091926364
Tax burden factor: 1.1182943603851443
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CHMG (annual period ending 2022-12-31)
ROE: 17.29872346563454%
Net margin: 30.421502103282812%
Asset turnover: 0.03576341127922971
Equity multiplier (leverage): 15.899902637209415
Tax burden factor: 0.7802596980129578
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CHMG (annual period ending 2023-12-31)
ROE: 13.82632476930777%
Net margin: 25.520881184985555%
Asset turnover: 0.03657860353893014
Equity multiplier (leverage): 14.810985844608702
Tax burden factor: 0.7936255991873273
ROE archetype: Standard Business
DuPont ROE decomposition for CHMG (annual period ending 2024-12-31)
ROE: 11.531360370235051%
Net margin: 24.62983965788132%
Asset turnover: 0.03503286871686974
Equity multiplier (leverage): 13.364208987943003
Tax burden factor: 0.7868040551769985
ROE archetype: Standard Business
DuPont ROE decomposition for CHMG (annual period ending 2025-12-31)
ROE: 6.426987902590965%
Net margin: 16.076636508781267%
Asset turnover: 0.03424843548990938
Equity multiplier (leverage): 11.672706151679298
Tax burden factor: 0.7576243980738363
ROE archetype: Standard Business
DuPont ROE decomposition for CHOLAHLDNG.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 8.328224220344042
ROE archetype: Standard Business
DuPont ROE decomposition for CHOLAHLDNG.NS (quarterly period ending 2025-03-31)
ROE: 5.0546419192633225%
Net margin: 14.309019268403622%
Asset turnover: 0.04238225290768531
Equity multiplier (leverage): 8.334825034908416
EBIT margin: 18.531512973582235%
Interest burden factor: 1.0556755377944054
Tax burden factor: 0.7314228644146973
ROE archetype: Standard Business
DuPont ROE decomposition for CHOLAHLDNG.NS (quarterly period ending 2025-06-30)
Net margin: 13.258483265051769%
EBIT margin: 15.526301384859595%
Interest burden factor: 1.1499138971375884
Tax burden factor: 0.7426095159483521
ROE archetype: Standard Business
DuPont ROE decomposition for CHOLAHLDNG.NS (quarterly period ending 2025-09-30)
ROE: 4.120688280198798%
Net margin: 11.989711284015957%
Asset turnover: 0.04221911217304117
Equity multiplier (leverage): 8.140516125310304
EBIT margin: 15.085607646431534%
Interest burden factor: 1.0680385650048108
Tax burden factor: 0.7441474236407315
ROE archetype: Low Return
DuPont ROE decomposition for CHOLAHLDNG.NS (quarterly period ending 2025-12-31)
Net margin: 13.247857936985158%
EBIT margin: 15.042477996235437%
Interest burden factor: 1.184074227066188
Tax burden factor: 0.7437848862172607
ROE archetype: Standard Business
DuPont ROE decomposition for CHOLAHLDNG.NS (quarterly period ending 2026-03-31)
ROE: 4.797969064898539%
Net margin: 14.99514321743165%
Asset turnover: 0.04039950849080202
Equity multiplier (leverage): 7.9201014404975645
EBIT margin: 18.322108461686764%
Interest burden factor: 1.078496231516305
Tax burden factor: 0.7588510447593972
ROE archetype: Low Return
DuPont ROE decomposition for CHR.TO (annual period ending 2022-12-31)
ROE: 4.093035209862955%
Net margin: 3.2533443956776646%
Asset turnover: 0.39345162822933155
Equity multiplier (leverage): 3.197599696631171
EBIT margin: 11.797564111883414%
Interest burden factor: 0.39226413691266615
Tax burden factor: 0.7030060934326336
ROE archetype: Low Return
DuPont ROE decomposition for CHR.TO (annual period ending 2023-12-31)
ROE: 8.44932433995143%
Net margin: 7.581106464581944%
Asset turnover: 0.3594513708317239
Equity multiplier (leverage): 3.100624980202041
EBIT margin: 11.326718638250199%
Interest burden factor: 0.8644672932567967
Tax burden factor: 0.7742476868742886
ROE archetype: Standard Business
DuPont ROE decomposition for CHR.TO (annual period ending 2024-12-31)
ROE: -16.475922896505775%
Net margin: -11.135524721805838%
Asset turnover: 0.48623817980381673
Equity multiplier (leverage): 3.0429163061383653
EBIT margin: 6.5942372490487235%
Interest burden factor: -0.02818254430844289
ROE archetype: Low Return
DuPont ROE decomposition for CHR.TO (annual period ending 2025-12-31)
ROE: 15.774543145583312%
Net margin: 5.980943381607872%
Asset turnover: 0.9238212043619175
Equity multiplier (leverage): 2.8549543787055436
EBIT margin: 7.5659059109850535%
Interest burden factor: 0.9903117313387884
Tax burden factor: 0.7982461476074615
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CIE.MC (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 3.1144664333958043
ROE archetype: Standard Business
DuPont ROE decomposition for CIE.MC (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 3.1086572283605296
ROE archetype: Standard Business
DuPont ROE decomposition for CIE.MC (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 3.0880381951015354
ROE archetype: Standard Business
DuPont ROE decomposition for CIF (quarterly period ending 2024-11-30)
Equity multiplier (leverage): 1.4518936656751613
ROE archetype: Standard Business
DuPont ROE decomposition for CIF (quarterly period ending 2025-05-31)
Equity multiplier (leverage): 1.4612210793510743
ROE archetype: Standard Business
DuPont ROE decomposition for CIF (quarterly period ending 2025-11-30)
Equity multiplier (leverage): 1.4677710390590362
ROE archetype: Standard Business
DuPont ROE decomposition for CIS.DE (annual period ending 2022-07-31)
ROE: 29.698539210016843%
Net margin: 22.91056500572182%
Asset turnover: 0.5484670538924704
Equity multiplier (leverage): 2.363462650541825
EBIT margin: 27.105921601334444%
Interest burden factor: 1.0359212880143114
Tax burden factor: 0.8159148994957519
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CIS.DE (annual period ending 2023-07-31)
ROE: 29.98597342082115%
Net margin: 22.12884662619741%
Asset turnover: 0.5820458096337068
Equity multiplier (leverage): 2.328103083470033
EBIT margin: 27.30271237587284%
Interest burden factor: 0.9843207813905668
Tax burden factor: 0.8234103668886278
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CIS.DE (annual period ending 2024-07-31)
ROE: 22.9818505734328%
Net margin: 19.18108655651172%
Asset turnover: 0.4755750999933706
Equity multiplier (leverage): 2.519374234495045
EBIT margin: 24.106462464918312%
Interest burden factor: 0.9432536622976099
Tax burden factor: 0.8435507601765572
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CIS.DE (annual period ending 2025-07-31)
ROE: 22.058504875406285%
Net margin: 17.968722420305717%
Asset turnover: 0.45928724301186846
Equity multiplier (leverage): 2.67284940411701
EBIT margin: 22.070815829420695%
Interest burden factor: 0.8877159309021113
Tax burden factor: 0.9171171171171171
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CKT.L (quarterly period ending 2025-01-31)
Equity multiplier (leverage): 1.7927927927927927
ROE archetype: Standard Business
DuPont ROE decomposition for CKT.L (quarterly period ending 2025-07-31)
Equity multiplier (leverage): 1.868952258891381
ROE archetype: Standard Business
DuPont ROE decomposition for CKT.L (quarterly period ending 2026-01-31)
Equity multiplier (leverage): 1.9542483660130718
ROE archetype: Standard Business
DuPont ROE decomposition for CLBX.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.3805108182853425
ROE archetype: Standard Business
DuPont ROE decomposition for CLBX.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.7487493051695386
ROE archetype: Standard Business
DuPont ROE decomposition for CLDN.L (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.011138910785893
ROE archetype: Standard Business
DuPont ROE decomposition for CLDN.L (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 1.010083618107906
ROE archetype: Standard Business
DuPont ROE decomposition for CLDN.L (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 1.0066170676230892
ROE archetype: Standard Business
DuPont ROE decomposition for CLDN.L (quarterly period ending 2026-03-31)
Equity multiplier (leverage): 1.0048009698065816
ROE archetype: Standard Business
DuPont ROE decomposition for CLIP.V (quarterly period ending 2024-12-31)
Net margin: -179.9322314652276%
Asset turnover: 0.12014179682109692
EBIT margin: -147.231265550908%
ROE archetype: Standard Business
DuPont ROE decomposition for CLIP.V (quarterly period ending 2025-03-31)
Net margin: -234.42653792615653%
Asset turnover: 0.0998321737806017
EBIT margin: -192.14922083342756%
ROE archetype: Standard Business
DuPont ROE decomposition for CLIP.V (quarterly period ending 2025-06-30)
Net margin: -161.08816993643242%
Asset turnover: 0.14604187144498526
EBIT margin: -112.38771564930605%
ROE archetype: Standard Business
DuPont ROE decomposition for CLIP.V (quarterly period ending 2025-09-30)
Net margin: -201.30107885678942%
Asset turnover: 0.15184676230892882
EBIT margin: -129.14689714601383%
ROE archetype: Standard Business
DuPont ROE decomposition for CLIP.V (quarterly period ending 2025-12-31)
Net margin: -87.07081042593411%
Asset turnover: 0.2042894459828855
EBIT margin: -82.11883413716946%
ROE archetype: Standard Business
DuPont ROE decomposition for CLIP.V (quarterly period ending 2026-03-31)
Net margin: -133.88400503635475%
Asset turnover: 0.196466504248158
EBIT margin: -84.23218276069375%
ROE archetype: Standard Business
DuPont ROE decomposition for CLMB (annual period ending 2022-12-31)
ROE: 20.630963779839533%
Net margin: 4.106154796482973%
Asset turnover: 1.312659581809399
Equity multiplier (leverage): 3.8276488262290753
EBIT margin: 5.8801109256509%
Interest burden factor: 0.9237818506928923
Tax burden factor: 0.7559278974110816
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CLMB (annual period ending 2023-12-31)
ROE: 18.209894786617802%
Net margin: 3.500722984662498%
Asset turnover: 1.241769173513195
Equity multiplier (leverage): 4.1889851046222955
EBIT margin: 4.863172666918551%
Interest burden factor: 0.980255856066359
Tax burden factor: 0.7343424110601275
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CLMB (annual period ending 2024-12-31)
ROE: 22.50873861560977%
Net margin: 3.996933035800579%
Asset turnover: 1.1578274649156945
Equity multiplier (leverage): 4.863852973548301
EBIT margin: 6.508278440831002%
Interest burden factor: 0.8255948255948256
Tax burden factor: 0.7438644176193141
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CLMB (annual period ending 2025-12-31)
ROE: 20.592082715876565%
Net margin: 3.2688803510100115%
Asset turnover: 1.4041501508480632
Equity multiplier (leverage): 4.4862936664623225
EBIT margin: 4.596355343998701%
Interest burden factor: 0.9308482261936516
Tax burden factor: 0.7640232108317214
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CLN.SW (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 2.4976076555023923
ROE archetype: Standard Business
DuPont ROE decomposition for CLN.SW (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 2.6906507791017416
ROE archetype: Standard Business
DuPont ROE decomposition for CLNX.MC (quarterly period ending 2025-03-31)
ROE: -0.3252788104089219%
Net margin: -5.08298755186722%
Asset turnover: 0.02244000093112037
Equity multiplier (leverage): 2.8517657992565058
EBIT margin: 15.45643153526971%
Interest burden factor: -0.5704697986577181
ROE archetype: Low Return
DuPont ROE decomposition for CLNX.MC (quarterly period ending 2025-06-30)
ROE: -0.4682786275313727%
Net margin: -6.3491849850744835%
Asset turnover: 0.025266432211303497
Equity multiplier (leverage): 2.919056057896589
EBIT margin: 3.6118308153033416%
Interest burden factor: -2.359631611168783
ROE archetype: Low Return
DuPont ROE decomposition for CLNX.MC (quarterly period ending 2025-09-30)
ROE: -1.0462521938600688%
Net margin: -14.874371859296481%
Asset turnover: 0.02340919134724766
Equity multiplier (leverage): 3.0047706979258546
EBIT margin: 17.386934673366834%
Interest burden factor: -0.9826589595375722
ROE archetype: Low Return
DuPont ROE decomposition for CLNX.MC (quarterly period ending 2025-12-31)
ROE: -0.5611633794969269%
Net margin: -6.479910957636423%
Asset turnover: 0.02803011343796197
Equity multiplier (leverage): 3.0895514260889887
EBIT margin: 7.599109914414197%
Interest burden factor: -1.198683230089972
ROE archetype: Low Return
DuPont ROE decomposition for CLNX.MC (quarterly period ending 2026-03-31)
ROE: -0.2756226425371508%
Net margin: -3.760162601626016%
Asset turnover: 0.02290761737010507
Equity multiplier (leverage): 3.199840612377388
EBIT margin: 16.260162601626014%
Interest burden factor: -0.25625
ROE archetype: Low Return
DuPont ROE decomposition for CLSK (annual period ending 2022-09-30)
ROE: -14.189182499529718%
Net margin: -43.58563010834442%
Asset turnover: 0.29058271195802265
Equity multiplier (leverage): 1.1203256338920626
EBIT margin: -12.59532408287398%
ROE archetype: Low Return
DuPont ROE decomposition for CLSK (annual period ending 2023-09-30)
ROE: -25.59054534676941%
Net margin: -82.0317324592656%
Asset turnover: 0.2773967779687581
Equity multiplier (leverage): 1.1245952504445762
EBIT margin: -73.21861194242554%
ROE archetype: Low Return
DuPont ROE decomposition for CLSK (annual period ending 2024-09-30)
ROE: -11.966054711884915%
Net margin: -38.46683625002639%
Asset turnover: 0.2782192464687399
Equity multiplier (leverage): 1.1180914989437758
EBIT margin: -15.632718329779824%
ROE archetype: Low Return
DuPont ROE decomposition for CLSK (annual period ending 2025-09-30)
ROE: 18.51966276148587%
Net margin: 47.56066051253141%
Asset turnover: 0.29781203674178675
Equity multiplier (leverage): 1.3075037703558565
EBIT margin: -13.967251022426838%
Tax burden factor: 0.9030886452332281
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CLYM (annual period ending 2022-12-31)
ROE: -35.150526356679485%
Asset turnover: 0
Equity multiplier (leverage): 1.0487666550130132
ROE archetype: Low Return
DuPont ROE decomposition for CLYM (annual period ending 2023-12-31)
ROE: -29.72231860998502%
Asset turnover: 0
Equity multiplier (leverage): 1.038706974618516
ROE archetype: Low Return
DuPont ROE decomposition for CLYM (annual period ending 2024-12-31)
ROE: -46.26079879804683%
Asset turnover: 0
Equity multiplier (leverage): 1.0255915863277827
ROE archetype: Low Return
DuPont ROE decomposition for CLYM (annual period ending 2025-12-31)
ROE: -32.14719247172061%
Asset turnover: 0
Equity multiplier (leverage): 1.0337714445315773
ROE archetype: Low Return
DuPont ROE decomposition for CMBN.SW (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 6.185219711512645
ROE archetype: Standard Business
DuPont ROE decomposition for CMBN.SW (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 6.272999798919486
ROE archetype: Standard Business
DuPont ROE decomposition for CMBN.SW (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 6.118451076008527
ROE archetype: Standard Business
DuPont ROE decomposition for CMBT (quarterly period ending 2025-03-31)
ROE: 1.67743386702301%
Net margin: 18.71904834839434%
Asset turnover: 0.02855513870157727
Equity multiplier (leverage): 3.1381765083770654
EBIT margin: 23.955089259883255%
Interest burden factor: 0.6835982594796199
Tax burden factor: 1.1431021044427125
ROE archetype: Low Return
DuPont ROE decomposition for CMBT (quarterly period ending 2025-06-30)
ROE: 0.3122057334676312%
Net margin: 2.003053057182936%
Asset turnover: 0.04846292248449128
Equity multiplier (leverage): 3.2161687010279145
EBIT margin: 15.465127073190857%
Interest burden factor: -0.04770320967069612
ROE archetype: Low Return
DuPont ROE decomposition for CMBT (quarterly period ending 2025-09-30)
ROE: 0.7792010718720058%
Net margin: 4.3747028055159305%
Asset turnover: 0.054190662618424416
Equity multiplier (leverage): 3.2868245733009527
EBIT margin: 19.7306317254011%
Interest burden factor: 0.20265324794144557
Tax burden factor: 1.0940923856191158
ROE archetype: Low Return
DuPont ROE decomposition for CMBT (quarterly period ending 2025-12-31)
ROE: 3.4444595498006514%
Net margin: 15.120717172060171%
Asset turnover: 0.07023788136275896
Equity multiplier (leverage): 3.243226617537086
EBIT margin: 27.85052124011002%
Interest burden factor: 0.5824097443212992
Tax burden factor: 0.9322028575914586
ROE archetype: Low Return
DuPont ROE decomposition for CMBT (quarterly period ending 2026-03-31)
ROE: 13.11097171079732%
Net margin: 70.98012047033465%
Asset turnover: 0.06091782881388567
Equity multiplier (leverage): 3.0321712951055853
EBIT margin: 33.03696861228181%
Interest burden factor: 2.155367856934817
Tax burden factor: 0.9968163194707198
ROE archetype: Standard Business
DuPont ROE decomposition for CMCM (quarterly period ending 2024-12-31)
ROE: -16.440882849461243%
Net margin: -153.05265111413854%
Asset turnover: 0.04307340750442245
Equity multiplier (leverage): 2.493877105339704
EBIT margin: -22.878750173985296%
ROE archetype: Low Return
DuPont ROE decomposition for CMCM (quarterly period ending 2025-03-31)
ROE: -1.2829233886125657%
Net margin: -10.852644340285554%
Asset turnover: 0.049916250342191444
Equity multiplier (leverage): 2.3682262896051554
EBIT margin: -10.24493641073952%
ROE archetype: Low Return
DuPont ROE decomposition for CMCM (quarterly period ending 2025-06-30)
ROE: -0.7603116590213171%
Net margin: -5.569782330345711%
Asset turnover: 0.05855836179722213
Equity multiplier (leverage): 2.3311193458190673
EBIT margin: -3.747400226273466%
ROE archetype: Low Return
DuPont ROE decomposition for CMCM (quarterly period ending 2025-09-30)
ROE: -0.17085957560657317%
Net margin: -1.2889351321819682%
Asset turnover: 0.05643387782138458
Equity multiplier (leverage): 2.348920771591081
EBIT margin: 1.3682756316791305%
Interest burden factor: 2.4928789420142423
Tax burden factor: -0.3778820648847174
ROE archetype: Low Return
DuPont ROE decomposition for CMCM (quarterly period ending 2025-12-31)
ROE: -9.101585452162832%
Net margin: -60.51332195783728%
Asset turnover: 0.06447442146490491
Equity multiplier (leverage): 2.3328058853112084
EBIT margin: -33.74248423997332%
ROE archetype: Low Return
DuPont ROE decomposition for CMCM (quarterly period ending 2026-03-31)
ROE: -0.6186102893891743%
Net margin: -4.6008965493275875%
Asset turnover: 0.05729395680799219
Equity multiplier (leverage): 2.3467447488343143
EBIT margin: -10.922302919383922%
ROE archetype: Low Return
DuPont ROE decomposition for CMCSA (quarterly period ending 2025-03-31)
ROE: 3.865979381443299%
Net margin: 11.292535215980191%
Asset turnover: 0.1116144452328491
Equity multiplier (leverage): 3.0672394043528066
EBIT margin: 18.934653862883525%
Interest burden factor: 0.7937798197561406
Tax burden factor: 0.7513357079252003
ROE archetype: Low Return
DuPont ROE decomposition for CMCSA (quarterly period ending 2025-06-30)
ROE: 12.040615291354095%
Net margin: 36.69382773067661%
Asset turnover: 0.1119345666703593
Equity multiplier (leverage): 2.931510408209658
EBIT margin: 19.770395539867383%
Interest burden factor: 2.4440180210245286
Tax burden factor: 0.7594046562435993
ROE archetype: Standard Business
DuPont ROE decomposition for CMCSA (quarterly period ending 2025-09-30)
ROE: 3.4157893118189184%
Net margin: 10.680171805884992%
Asset turnover: 0.11410180215600399
Equity multiplier (leverage): 2.8029821521933016
EBIT margin: 17.73511122507853%
Interest burden factor: 0.8075185252123622
Tax burden factor: 0.7457475380483438
ROE archetype: Low Return
DuPont ROE decomposition for CMCSA (quarterly period ending 2025-12-31)
ROE: 2.223452915718007%
Net margin: 6.709996904982978%
Asset turnover: 0.11843277263180274
Equity multiplier (leverage): 2.797909872212992
EBIT margin: 10.789229340761375%
Interest burden factor: 0.6193344807802639
Tax burden factor: 1.0041685965724874
ROE archetype: Low Return
DuPont ROE decomposition for CMCSA (quarterly period ending 2026-03-31)
ROE: 2.338690591449902%
Net margin: 6.911021394284261%
Asset turnover: 0.11811885482123714
Equity multiplier (leverage): 2.8649121108457583
EBIT margin: 13.144927996948216%
Interest burden factor: 0.6609431680773882
Tax burden factor: 0.7954628613245518
ROE archetype: Low Return
DuPont ROE decomposition for CMCSA (quarterly period ending 2026-06-30)
ROE: 3.950810947085352%
Net margin: 11.77688710754843%
Asset turnover: 0.11569896628345087
Equity multiplier (leverage): 2.899520994985854
EBIT margin: 17.234468937875754%
Interest burden factor: 0.8937984496124031
Tax burden factor: 0.7645273200346921
ROE archetype: Low Return
DuPont ROE decomposition for CMCT (quarterly period ending 2025-03-31)
ROE: -1.9382818592795958%
Net margin: -18.93172317696238%
Asset turnover: 0.036601412375912766
Equity multiplier (leverage): 2.79723492077582
EBIT margin: 14.813438612788357%
Interest burden factor: -1.2857441471571907
ROE archetype: Low Return
DuPont ROE decomposition for CMCT (quarterly period ending 2025-06-30)
ROE: -2.9207670137356216%
Net margin: -30.31088955505406%
Asset turnover: 0.03359687037270697
Equity multiplier (leverage): 2.868133811959598
EBIT margin: 9.202061369530803%
Interest burden factor: -3.291727672035139
ROE archetype: Low Return
DuPont ROE decomposition for CMCT (quarterly period ending 2025-09-30)
ROE: -4.267420446271789%
Net margin: -47.47655713958985%
Asset turnover: 0.02986481486751857
Equity multiplier (leverage): 3.009722043770611
EBIT margin: -6.037965998322787%
ROE archetype: Low Return
DuPont ROE decomposition for CMCT (quarterly period ending 2025-12-31)
ROE: -4.163874726875455%
Net margin: -40.188394081051634%
Asset turnover: 0.03287208126108816
Equity multiplier (leverage): 3.1518809176984703
EBIT margin: 13.409019015148852%
Interest burden factor: -2.9939711664482305
ROE archetype: Low Return
DuPont ROE decomposition for CMCT (quarterly period ending 2026-03-31)
ROE: -3.176927606273562%
Net margin: -28.245572288132713%
Asset turnover: 0.03562441114423908
Equity multiplier (leverage): 3.1572519901201335
EBIT margin: 3.596559812353401%
Interest burden factor: -7.955576559546314
ROE archetype: Low Return
DuPont ROE decomposition for CME (quarterly period ending 2025-03-31)
ROE: 3.5374592592866625%
Net margin: 58.22322352797905%
Asset turnover: 0.010405394103588888
Equity multiplier (leverage): 5.838975683204652
EBIT margin: 67.46635815624428%
Interest burden factor: 1.1234657039711191
Tax burden factor: 0.768155526992288
ROE archetype: Low Return
DuPont ROE decomposition for CME (quarterly period ending 2025-06-30)
ROE: 3.7433106261308717%
Net margin: 60.58510638297873%
Asset turnover: 0.010019583192445282
Equity multiplier (leverage): 6.1665227306339085
EBIT margin: 66.74349881796691%
Interest burden factor: 1.1779863632338616
Tax burden factor: 0.7705780650980981
ROE archetype: Low Return
DuPont ROE decomposition for CME (quarterly period ending 2025-09-30)
ROE: 3.24695642534414%
Net margin: 59.05306971904266%
Asset turnover: 0.008378113594927798
Equity multiplier (leverage): 6.5627783648284534
EBIT margin: 63.25442247658689%
Interest burden factor: 1.210158338474193
Tax burden factor: 0.7714528462192014
ROE archetype: Low Return
DuPont ROE decomposition for CME (quarterly period ending 2025-12-31)
ROE: 4.156469337737291%
Net margin: 71.74743737490144%
Asset turnover: 0.008552040517801233
Equity multiplier (leverage): 6.774050616231981
EBIT margin: 61.84266391702553%
Interest burden factor: 1.548058061985092
Tax burden factor: 0.7494298023314749
ROE archetype: Low Return
DuPont ROE decomposition for CME (quarterly period ending 2026-03-31)
ROE: 4.220690053914979%
Net margin: 62.124355087495346%
Asset turnover: 0.009390693768032731
Equity multiplier (leverage): 7.234756009424281
EBIT margin: 69.66118823466837%
Interest burden factor: 1.1536229670917004
Tax burden factor: 0.7730491759878219
ROE archetype: Low Return
DuPont ROE decomposition for CMG (annual period ending 2022-12-31)
ROE: 37.96842344858982%
Net margin: 10.41270684678433%
Asset turnover: 1.2464304603793805
Equity multiplier (leverage): 2.9254378019132417
EBIT margin: 14.02606613445452%
Interest burden factor: 0.9755833942970947
Tax burden factor: 0.7609626831627778
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CMG (annual period ending 2023-12-31)
ROE: 45.25543116958213%
Net margin: 12.447130160320732%
Asset turnover: 1.3186932076469293
Equity multiplier (leverage): 2.757132939120442
EBIT margin: 16.543477184004416%
Interest burden factor: 0.9922797796112213
Tax burden factor: 0.758242795768729
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CMG (annual period ending 2024-12-31)
ROE: 45.673307726556786%
Net margin: 13.559571615434635%
Asset turnover: 1.3118471985425484
Equity multiplier (leverage): 2.567634743343496
EBIT margin: 17.54644505280385%
Interest burden factor: 1.0126190131972985
Tax burden factor: 0.763151480178885
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CMG (annual period ending 2025-12-31)
ROE: 47.3550654756371%
Net margin: 12.877849929743581%
Asset turnover: 1.3105844554933388
Equity multiplier (leverage): 2.8058087744769513
EBIT margin: 16.878042456728178%
Interest burden factor: 0.9983659643642115
Tax burden factor: 0.7642430850367675
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CMIN3.SA (annual period ending 2022-12-31)
ROE: 25.89473737796363%
Net margin: 22.22854604430614%
Asset turnover: 0.529766845835897
Equity multiplier (leverage): 2.198951641152394
EBIT margin: 35.40475675988453%
Interest burden factor: 0.847052819900922
Tax burden factor: 0.7412060389880218
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CMIN3.SA (annual period ending 2023-12-31)
ROE: 33.72419967210053%
Net margin: 18.90178219495683%
Asset turnover: 0.7164723584378491
Equity multiplier (leverage): 2.4902299813923343
EBIT margin: 34.792000985570986%
Interest burden factor: 0.7317167406671276
Tax burden factor: 0.7424724719851504
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CMIN3.SA (annual period ending 2024-12-31)
ROE: 37.886198023095204%
Net margin: 27.44684768121272%
Asset turnover: 0.444503981027459
Equity multiplier (leverage): 3.1053667445378084
EBIT margin: 26.897161348196697%
Interest burden factor: 1.2957117141806893
Tax burden factor: 0.7875490987673605
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CMIN3.SA (annual period ending 2025-12-31)
ROE: 20.89912880605527%
Net margin: 9.151933016150071%
Asset turnover: 0.5476883704964893
Equity multiplier (leverage): 4.1694793811599675
EBIT margin: 27.234236042021582%
Interest burden factor: 0.4987449592626121
Tax burden factor: 0.6737815524879909
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CMMB (annual period ending 2022-12-31)
ROE: -76.32167407448306%
Asset turnover: 0
Equity multiplier (leverage): 1.1888303011898518
ROE archetype: Low Return
DuPont ROE decomposition for CMMB (annual period ending 2023-12-31)
ROE: -89.2955523424944%
Asset turnover: 0
Equity multiplier (leverage): 1.2246733421765248
ROE archetype: Low Return
DuPont ROE decomposition for CMMB (annual period ending 2024-12-31)
ROE: -90.92136297842843%
Asset turnover: 0
Equity multiplier (leverage): 1.281132919781789
ROE archetype: Low Return
DuPont ROE decomposition for CMMB (annual period ending 2025-12-31)
ROE: -74.56104891334711%
Asset turnover: 0
Equity multiplier (leverage): 1.1850023777416132
ROE archetype: Low Return
DuPont ROE decomposition for CMPR (quarterly period ending 2025-03-31)
Net margin: -1.0158739809593298%
Asset turnover: 0.4203062743436141
EBIT margin: 5.194257398653271%
Interest burden factor: 0.10056819567390933
Tax burden factor: -1.944713870029098
ROE archetype: Standard Business
DuPont ROE decomposition for CMPR (quarterly period ending 2025-06-30)
Net margin: -2.911845314974531%
Asset turnover: 0.46954098392718413
EBIT margin: 8.078478820172446%
Interest burden factor: 0.19159750003559176
Tax burden factor: -1.8812602169713182
ROE archetype: Standard Business
DuPont ROE decomposition for CMPR (quarterly period ending 2025-09-30)
Net margin: 0.8846523190123216%
Asset turnover: 0.43880361452060324
EBIT margin: 5.7072063775589985%
Interest burden factor: 0.49438795185613676
Tax burden factor: 0.31353148862796615
ROE archetype: Standard Business
DuPont ROE decomposition for CMPR (quarterly period ending 2025-12-31)
Net margin: 4.748599599693725%
Asset turnover: 0.5132852061657147
EBIT margin: 8.57808754924669%
Interest burden factor: 0.7027550027404615
Tax burden factor: 0.7877186559918505
ROE archetype: Standard Business
DuPont ROE decomposition for CMPR (quarterly period ending 2026-03-31)
Net margin: 1.6523190353517063%
Asset turnover: 0.42214980441759503
EBIT margin: 5.865659229369145%
Interest burden factor: 0.5069447116309491
Tax burden factor: 0.5556693989071039
ROE archetype: Standard Business
DuPont ROE decomposition for CMTG (quarterly period ending 2025-03-31)
ROE: -4.064075757849875%
Asset turnover: -0.0021361987050900993
Equity multiplier (leverage): 3.4406428252054058
ROE archetype: Low Return
DuPont ROE decomposition for CMTG (quarterly period ending 2025-06-30)
ROE: -9.844309333448912%
Net margin: -532.1628349685167%
Asset turnover: 0.005472245402760948
Equity multiplier (leverage): 3.380454895757006
ROE archetype: Low Return
DuPont ROE decomposition for CMTG (quarterly period ending 2025-09-30)
ROE: -0.5435500354979019%
Net margin: -18.47478331685184%
Asset turnover: 0.009156610205963808
Equity multiplier (leverage): 3.2131089230800827
ROE archetype: Low Return
DuPont ROE decomposition for CMTG (quarterly period ending 2025-12-31)
ROE: -13.363647946509074%
Net margin: -5172.51061821614%
Asset turnover: 0.0008339822376345603
Equity multiplier (leverage): 3.097896001653303
ROE archetype: Low Return
DuPont ROE decomposition for CMTG (quarterly period ending 2026-03-31)
ROE: -3.5899909512973496%
Net margin: -417.77469990766394%
Asset turnover: 0.0029249989618684432
Equity multiplier (leverage): 2.9378221554690764
ROE archetype: Low Return
DuPont ROE decomposition for CMU (annual period ending 2022-11-30)
ROE: -26.44130176942644%
Asset turnover: -0.15641186940439072
Equity multiplier (leverage): 1.67380140120525
ROE archetype: Low Return
DuPont ROE decomposition for CMU (annual period ending 2023-11-30)
ROE: 1.2795383351258165%
Net margin: 77.39022667217479%
Asset turnover: 0.009897155400966005
Equity multiplier (leverage): 1.6705396723447785
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CMU (annual period ending 2024-11-30)
ROE: 12.875805459277206%
Net margin: 1242.167049807486%
Asset turnover: 0.006352432215937346
Equity multiplier (leverage): 1.6317527824395643
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CMU (annual period ending 2025-11-30)
ROE: -0.018131418714776658%
Net margin: -25.75248916817308%
Asset turnover: 0.0004349780596684782
Equity multiplier (leverage): 1.6186211932840195
ROE archetype: Low Return
DuPont ROE decomposition for CMX.L (annual period ending 2022-06-30)
ROE: 68.83975101040456%
Net margin: 97827.08800000002%
Asset turnover: 0.00070264264460751
Equity multiplier (leverage): 1.0014877935318516
EBIT margin: -451.4360000000001%
Tax burden factor: 1.0009805255759519
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CMX.L (annual period ending 2023-06-30)
ROE: 7.362472331394554%
Net margin: 10458.184%
Asset turnover: 0.000702811078450387
Equity multiplier (leverage): 1.0016795294496426
EBIT margin: -617.788%
Tax burden factor: 1.0117248899679057
ROE archetype: Standard Business
DuPont ROE decomposition for CMX.L (annual period ending 2024-06-30)
ROE: 0.8305612153326261%
Net margin: 1132.74%
Asset turnover: 0.0007318896468500714
Equity multiplier (leverage): 1.0018340918593927
EBIT margin: -579.768%
Tax burden factor: 1.1251564455569463
ROE archetype: Low Return
DuPont ROE decomposition for CMX.L (annual period ending 2025-06-30)
ROE: 1.2914640903939274%
Net margin: 1548.4800000000002%
Asset turnover: 0.000832562564300269
Equity multiplier (leverage): 1.0017511631084912
EBIT margin: -483.82000000000005%
Tax burden factor: 1.0794713066755899
ROE archetype: Low Return
DuPont ROE decomposition for CNI (quarterly period ending 2025-03-31)
ROE: 5.369034406215315%
Net margin: 26.368385191914605%
Asset turnover: 0.07670330818946744
Equity multiplier (leverage): 2.65459674435812
EBIT margin: 36.56597774244833%
Interest burden factor: 0.9484472049689441
Tax burden factor: 0.7603143418467584
ROE archetype: Standard Business
DuPont ROE decomposition for CNI (quarterly period ending 2025-06-30)
ROE: 5.5475745663454115%
Net margin: 27.43445692883895%
Asset turnover: 0.07644236481365814
Equity multiplier (leverage): 2.645286203422101
EBIT margin: 38.34269662921348%
Interest burden factor: 0.952991452991453
Tax burden factor: 0.7508007687379885
ROE archetype: Standard Business
DuPont ROE decomposition for CNI (quarterly period ending 2025-09-30)
ROE: 5.282515544850501%
Net margin: 27.3469387755102%
Asset turnover: 0.07227210958108762
Equity multiplier (leverage): 2.672768434834345
EBIT margin: 38.5594237695078%
Interest burden factor: 0.9383561643835616
Tax burden factor: 0.7558062375580623
ROE archetype: Standard Business
DuPont ROE decomposition for CNI (quarterly period ending 2025-12-31)
ROE: 5.868120526632967%
Net margin: 27.956989247311824%
Asset turnover: 0.07737946667433192
Equity multiplier (leverage): 2.7125821140923083
EBIT margin: 38.821684587813614%
Interest burden factor: 0.9630698211194462
Tax burden factor: 0.7477531455961652
ROE archetype: Standard Business
DuPont ROE decomposition for CNI (quarterly period ending 2026-03-31)
ROE: 5.289166325149211%
Net margin: 26.1703585293446%
Asset turnover: 0.07367537998041948
Equity multiplier (leverage): 2.7431854423783837
EBIT margin: 35.37337291619091%
Interest burden factor: 0.9819238218205294
Tax burden factor: 0.7534516765285996
ROE archetype: Standard Business
DuPont ROE decomposition for CNL.TO (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.1499189395118905
ROE archetype: Standard Business
DuPont ROE decomposition for CNL.TO (quarterly period ending 2025-03-31)
ROE: -29.25362088242032%
Asset turnover: 0
Equity multiplier (leverage): 1.087282783151039
ROE archetype: Low Return
DuPont ROE decomposition for CNL.TO (quarterly period ending 2025-06-30)
ROE: -11.383564952902448%
Asset turnover: 0
Equity multiplier (leverage): 1.1317417419895313
ROE archetype: Low Return
DuPont ROE decomposition for CNL.TO (quarterly period ending 2025-12-31)
ROE: -9.348784781958951%
Asset turnover: 0
Equity multiplier (leverage): 1.0890129423819337
ROE archetype: Low Return
DuPont ROE decomposition for CNL.TO (quarterly period ending 2026-03-31)
ROE: -8.841474286569364%
Asset turnover: 0
Equity multiplier (leverage): 1.234354119308967
ROE archetype: Low Return
DuPont ROE decomposition for CNS (quarterly period ending 2025-03-31)
ROE: 6.7496476194040085%
Net margin: 30.956535419556914%
Asset turnover: 0.1674977391554323
Equity multiplier (leverage): 1.3017266649203558
EBIT margin: 36.1625595331741%
Interest burden factor: 1.0470841820087404
Tax burden factor: 0.8175448536355052
ROE archetype: Standard Business
DuPont ROE decomposition for CNS (quarterly period ending 2025-06-30)
ROE: 7.058030385081014%
Net margin: 29.325826131521122%
Asset turnover: 0.17963563631227425
Equity multiplier (leverage): 1.3398024623354592
EBIT margin: 34.85092073209259%
Interest burden factor: 1.0844446235042908
Tax burden factor: 0.7759408552216072
ROE archetype: Standard Business
DuPont ROE decomposition for CNS (quarterly period ending 2025-09-30)
ROE: 7.4379133684861864%
Net margin: 28.408456267963437%
Asset turnover: 0.18913137988001044
Equity multiplier (leverage): 1.3843308267458885
EBIT margin: 36.782994837426614%
Interest burden factor: 1.0287184994537746
Tax burden factor: 0.7507649663414809
ROE archetype: Standard Business
DuPont ROE decomposition for CNS (quarterly period ending 2025-12-31)
ROE: 5.750367857687504%
Net margin: 23.405583143202254%
Asset turnover: 0.17758382559557076
Equity multiplier (leverage): 1.3834795833831366
EBIT margin: 30.550932760703258%
Interest burden factor: 0.9288554044852505
Tax burden factor: 0.8247966326144532
ROE archetype: Standard Business
DuPont ROE decomposition for CNS (quarterly period ending 2026-03-31)
ROE: 6.5140550023139285%
Net margin: 28.068315821552076%
Asset turnover: 0.17436062706802438
Equity multiplier (leverage): 1.3310263234364839
EBIT margin: 36.72107906138619%
Interest burden factor: 1.0319327427880711
Tax burden factor: 0.7407122502141645
ROE archetype: Standard Business
DuPont ROE decomposition for CNTA (quarterly period ending 2025-03-31)
ROE: -6.766395596600103%
Net margin: -174.23333333333332%
Asset turnover: 0.02841743314798852
Equity multiplier (leverage): 1.3665996111296657
EBIT margin: -205.18%
ROE archetype: Low Return
DuPont ROE decomposition for CNTA (quarterly period ending 2025-06-30)
ROE: -14.159165679629806%
Asset turnover: 0
Equity multiplier (leverage): 1.395794932586177
ROE archetype: Low Return
DuPont ROE decomposition for CNTA (quarterly period ending 2025-09-30)
ROE: -16.857951385841677%
Asset turnover: 0
Equity multiplier (leverage): 1.454457010245166
ROE archetype: Low Return
DuPont ROE decomposition for CNTA (quarterly period ending 2025-12-31)
ROE: -15.972970787157017%
Asset turnover: 0
Equity multiplier (leverage): 1.3710095034384024
ROE archetype: Low Return
DuPont ROE decomposition for CNTA (quarterly period ending 2026-03-31)
ROE: -15.409783334520283%
Asset turnover: 0
Equity multiplier (leverage): 1.310553004559207
ROE archetype: Low Return
DuPont ROE decomposition for CNU.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 10.73721340388006
ROE archetype: Standard Business
DuPont ROE decomposition for CNXU (annual period ending 2024-10-31)
ROE: -496.89040057284865%
Asset turnover: 0
Equity multiplier (leverage): 5.622551703803547
ROE archetype: Low Return
DuPont ROE decomposition for CNXU (annual period ending 2025-10-31)
ROE: -105.3635257370204%
Asset turnover: 0
Equity multiplier (leverage): 1.104058766401299
ROE archetype: Low Return
DuPont ROE decomposition for COCH (quarterly period ending 2025-03-31)
Net margin: -10865.217391304348%
Asset turnover: 0.004429465575349061
EBIT margin: -11102.173913043478%
ROE archetype: Standard Business
DuPont ROE decomposition for COCH (quarterly period ending 2025-06-30)
Net margin: -7294.871794871794%
Asset turnover: 0.007690411634212472
EBIT margin: -6500%
ROE archetype: Standard Business
DuPont ROE decomposition for COCH (quarterly period ending 2025-09-30)
Net margin: -15433.333333333334%
Asset turnover: 0.004645760743321719
EBIT margin: -13590.476190476189%
ROE archetype: Standard Business
DuPont ROE decomposition for COCH (quarterly period ending 2025-12-31)
Net margin: -8781.333333333334%
Asset turnover: 0.008961108787860685
EBIT margin: -8513.333333333334%
ROE archetype: Standard Business
DuPont ROE decomposition for COCH (quarterly period ending 2026-03-31)
Net margin: -11156.410256410258%
Asset turnover: 0.0020323084940072956
EBIT margin: -15279.48717948718%
ROE archetype: Standard Business
DuPont ROE decomposition for CODE.OL (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.152596617116449
ROE archetype: Standard Business
DuPont ROE decomposition for CODE.OL (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.056753769025273
ROE archetype: Standard Business
DuPont ROE decomposition for CODE.OL (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.5307015565101718
ROE archetype: Standard Business
DuPont ROE decomposition for COI.AX (annual period ending 2022-06-30)
ROE: -18.159638237459248%
Equity multiplier (leverage): 2.300052581764644
ROE archetype: Low Return
DuPont ROE decomposition for COI.AX (annual period ending 2023-06-30)
ROE: -11.535213042603672%
Equity multiplier (leverage): 1.978847575354384
ROE archetype: Low Return
DuPont ROE decomposition for COI.AX (annual period ending 2024-06-30)
ROE: -10.447950512610253%
Equity multiplier (leverage): 1.6892396824056355
ROE archetype: Low Return
DuPont ROE decomposition for COI.AX (annual period ending 2025-06-30)
ROE: -3.18599955705577%
Equity multiplier (leverage): 1.6025532626247811
ROE archetype: Low Return
DuPont ROE decomposition for COLA (quarterly period ending 2025-03-31)
ROE: 0.24446782190397018%
Asset turnover: 0
Equity multiplier (leverage): 1.0007518659685937
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for COLA (quarterly period ending 2025-06-30)
ROE: 0.7692938855261963%
Asset turnover: 0
Equity multiplier (leverage): 1.0011823404167375
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for COLA (quarterly period ending 2025-09-30)
ROE: 0.8000097100199898%
Asset turnover: 0
Equity multiplier (leverage): 1.001648842306086
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for COLA (quarterly period ending 2025-12-31)
ROE: 0.2816330914897536%
Asset turnover: 0
Equity multiplier (leverage): 1.00334746031916
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for COLA (quarterly period ending 2026-03-31)
ROE: 0.1373083163380696%
Asset turnover: 0
Equity multiplier (leverage): 1.0078122082537955
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for COLB (annual period ending 2022-12-31)
ROE: 13.579662444058574%
Net margin: 26.525429603070076%
Asset turnover: 0.03986179754808361
Equity multiplier (leverage): 12.843094233224427
Tax burden factor: 0.7473778124986129
ROE archetype: Standard Business
DuPont ROE decomposition for COLB (annual period ending 2023-12-31)
ROE: 9.337967533840098%
Net margin: 17.47621432148222%
Asset turnover: 0.04753503641030258
Equity multiplier (leverage): 11.240643303018384
Tax burden factor: 0.7409766454352441
ROE archetype: Standard Business
DuPont ROE decomposition for COLB (annual period ending 2024-12-31)
ROE: 10.560628986316074%
Net margin: 27.682737169517885%
Asset turnover: 0.037185686968843716
Equity multiplier (leverage): 10.258998041537287
Tax burden factor: 0.7426981919332406
ROE archetype: Standard Business
DuPont ROE decomposition for COLB (annual period ending 2025-12-31)
ROE: 8.488964346349745%
Net margin: 23.90265102129509%
Asset turnover: 0.038865617188027834
Equity multiplier (leverage): 9.137829912023461
Tax burden factor: 0.7554945054945055
ROE archetype: Standard Business
DuPont ROE decomposition for COLD (quarterly period ending 2025-03-31)
ROE: -0.5088443548254319%
Net margin: -2.604216350281408%
Asset turnover: 0.08037693765375453
Equity multiplier (leverage): 2.430952337313482
EBIT margin: 7.5727368119813026%
Interest burden factor: -0.29323339841699736
ROE archetype: Low Return
DuPont ROE decomposition for COLD (quarterly period ending 2025-06-30)
ROE: 0.048708601420499945%
Net margin: 0.2381874396847935%
Asset turnover: 0.08177795561143017
Equity multiplier (leverage): 2.5006364328711412
EBIT margin: 8.342246153657022%
Interest burden factor: 0.08823475233481312
Tax burden factor: 0.3235908141962422
ROE archetype: Low Return
DuPont ROE decomposition for COLD (quarterly period ending 2025-09-30)
ROE: -0.3656865317418709%
Net margin: -1.7126110311678333%
Asset turnover: 0.08208314433239923
Equity multiplier (leverage): 2.60133475905823
EBIT margin: 6.934673366834171%
Interest burden factor: -0.3845468570062795
ROE archetype: Low Return
DuPont ROE decomposition for COLD (quarterly period ending 2025-12-31)
ROE: -2.9481660605652045%
Net margin: -13.41644733944564%
Asset turnover: 0.08127778037682254
Equity multiplier (leverage): 2.7036008667523452
EBIT margin: 8.293530441808299%
Interest burden factor: -1.9934076800527385
ROE archetype: Low Return
DuPont ROE decomposition for COLD (quarterly period ending 2026-03-31)
ROE: -0.4690461379203926%
Net margin: -2.152348897391525%
Asset turnover: 0.07773659356314298
Equity multiplier (leverage): 2.8033504086378946
EBIT margin: 5.1645577658881985%
Interest burden factor: -0.6227482324008607
ROE archetype: Low Return
DuPont ROE decomposition for COMPUSOFT.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.5958859059824397
ROE archetype: Standard Business
DuPont ROE decomposition for COMPUSOFT.NS (quarterly period ending 2024-12-31)
Net margin: 4.11068655244669%
EBIT margin: 0.28719339331936394%
Interest burden factor: 5.545064377682404
Tax burden factor: 2.581269349845201
ROE archetype: Standard Business
DuPont ROE decomposition for COMPUSOFT.NS (quarterly period ending 2025-03-31)
ROE: 0.6052006697411761%
Net margin: 8.85338052360381%
Asset turnover: 0.050370734689661426
Equity multiplier (leverage): 1.357100416346751
EBIT margin: 0.30604278353198355%
Interest burden factor: 46.054421768707485
Tax burden factor: 0.628138847858198
ROE archetype: Low Return
DuPont ROE decomposition for COMPUSOFT.NS (quarterly period ending 2025-06-30)
Net margin: 15.268697177483654%
EBIT margin: 9.68858919743946%
Interest burden factor: 2.1279097107923817
Tax burden factor: 0.7406077348066299
ROE archetype: Standard Business
DuPont ROE decomposition for COMPUSOFT.NS (quarterly period ending 2025-09-30)
ROE: 0.48725770061446083%
Net margin: 8.11056426961253%
Asset turnover: 0.04047763504249413
Equity multiplier (leverage): 1.4842002861717227
EBIT margin: 1.3914952377580285%
Interest burden factor: 9.36810856658185
Tax burden factor: 0.622181982797646
ROE archetype: Low Return
DuPont ROE decomposition for COMPUSOFT.NS (quarterly period ending 2025-12-31)
Net margin: -2.647003003137106%
EBIT margin: -3.693077154946245%
ROE archetype: Standard Business
DuPont ROE decomposition for COMPUSOFT.NS (quarterly period ending 2026-03-31)
ROE: 0.7640864590456413%
Net margin: 13.695227287056303%
Asset turnover: 0.03903473626388771
Equity multiplier (leverage): 1.4292954448881272
EBIT margin: -51.483513019355655%
Tax burden factor: 0.731528254866303
ROE archetype: Low Return
DuPont ROE decomposition for CORA.L (annual period ending 2022-12-31)
ROE: -10.394872855075459%
Asset turnover: 0
Equity multiplier (leverage): 1.0079801529873889
ROE archetype: Low Return